Inhibikase Therapeutics, Inc. - IKT

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 24
Latest filed: Jul 17, 2026
Form Count
4 9
SCHEDULE 13G/A 9
8-K 5
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
Jul 17, 2026 SCHEDULE 13G 0001346824-26-000193 View
Jul 14, 2026 8-K Jul 14, 2026 0001193125-26-302580 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290470 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290472 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290474 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290475 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290476 View
Jun 30, 2026 4 Jun 26, 2026 0001193125-26-290477 View
Jun 29, 2026 8-K Jun 26, 2026 0001193125-26-286747 View
May 15, 2026 SCHEDULE 13G/A 0001104659-26-062874 View
May 15, 2026 SCHEDULE 13G/A 0001193125-26-226561 View
May 15, 2026 SCHEDULE 13G/A 0001493152-26-023791 View
May 15, 2026 SCHEDULE 13G/A 0001831942-26-000019 View
May 12, 2026 8-K May 12, 2026 0001193125-26-219610 View
Apr 07, 2026 8-K Apr 07, 2026 0001193125-26-144582 View
Mar 26, 2026 8-K Mar 26, 2026 0001193125-26-126322 View
Feb 24, 2026 4 Feb 21, 2026 0001193125-26-068063 View
Feb 24, 2026 4 Feb 21, 2026 0001193125-26-068077 View
Feb 24, 2026 4 Feb 21, 2026 0001193125-26-068079 View
Feb 17, 2026 SCHEDULE 13G/A 0001193125-26-054524 View
Feb 17, 2026 SCHEDULE 13G/A 0001104659-26-016478 View
Feb 17, 2026 SCHEDULE 13G/A 0001104659-26-016623 View
Feb 13, 2026 SCHEDULE 13G/A 0001875620-26-000002 View
Feb 13, 2026 SCHEDULE 13G/A 0001104659-26-015334 View